• BioAge Labs principal accounting officer Shane Barton sold 62,566 shares on June 29-30, ending with zero shares owned.
• Sales priced at weighted-average USD 25.21 on June 29, weighted-average USD 25.19 on June 30.
• He exercised stock options for 63,934 shares on June 29-30 at USD 4.3 to USD 10.85 per share.
• He reported 67,941 stock options held following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioage Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001836297-26-000005), on July 01, 2026, and is solely responsible for the information contained therein.